设为首页 | 加入收藏
网站首页 本刊简介 编委会 投稿指南 过刊浏览 广告合作 网上订购 下载专区 联系我们  
未服药与短期服药治疗的精神分裂症患者执行功能的对照研究
作者:吴东辉1  高北陵1  吴冬凌1  郭金宏1  廖春平1  刘哲宁2 
单位:1. 深圳市精神卫生研究所  广东 深圳 518020 
2.
 中南大学湘雅二医院精神卫生研究所  湖南 长沙 410011 
关键词:精神分裂症 执行功能 威斯康星分类卡片测验 
分类号:R395.2
出版年,卷(期):页码:2009,17(2):167-168
摘要:

目的:探讨未服药与短期服药治疗的发作期精神分裂症患者执行功能的特点。方法:采用威斯康星分类卡片测验(WCST)分别对50名未服抗精神病药物、47名服药治疗不足1月的处于发作期、现病期在2年以内的分裂症患者和60名健康对照者的执行功能进行评估。结果:①在WCST中,未服药和服药的分裂症患者的总反应数、持续错误数、随机错误数、错误应答百分率和随机错误应答率均高于正常对照组(均P<0.05);两患者组正确反应数、完成分类数和正确应答百分率均低于对照组(均P<0.05)。②WCST中持续错误数与患者的性别、年龄、教育年限的相关关系无显著性(均P>0.05)。结论:未经治疗和短期治疗的急性发作期分裂症患者均存在执行功能缺陷。

Objective To explore the executive function of neuroleptic -naive and short -term medicated onset schizophrenic patients. Methods 55 drug naive patients and 49 patients with schizophrenia medicated for one month and 60 normal controls were administered the Wisconsin Card Sorting Test (WCST) to study the executive function. Results Compared with the controls, neuroleptic-naive patients and medicated patients showed higher level in the number of total trials, perseverant errors, random errors, the rate of error responses and the rate of random errors, while they showed lower level in the number of categories, correct trials and the rate of correct responses. There was no significant difference in WCST between the neuroleptic-naive patients and medicated patients. Conclusion Neuroleptic-naive and short-term medicated onset patients with schizophrenia may have executive dysfunction.

基金项目:
作者简介:
参考文献:

[1] Bellino S, Rocca P, Patria L, et al. Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients. J Clin Psychiatry,2004,65(7):908-914
[2] Addington J, Addington D. Cognitive functioning in first episode schizophrenia. Rev Psychiatr Neurosci,2002,27(3):188-192
[3] Nakano H, Terao T, Iwata N, et al. Symptomatological and cognitive predictors of insight in chronic schizophrenia. Psychiatry Res,2004,127(1-2):65-72
[4] 王湘,姚树桥,刘鼎,等.缺陷型及非缺陷型精神分裂症患者执行功能障碍的比较研究.中国临床心理学杂志,2007,15(4):352-355
[5] Bonilha L, Molnar C, Horner MD, et al. Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia. Schizophr Res,2008,101(1-3):142-151
[6] 杨莉和,关恒永.首发精神分裂症患者及其父母执行功能障碍的研究.四川精神卫生,2007,20(3):132-134
[7] 安宝富,李晏,王长虹.首发偏执型精神分裂症患者执行功能研究.中国行为医学科学,2006,15(4):340-341
[8] Lee SM, Chou YH, Li MH, et al. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry,2007,30(5):1101-1107
[9] Remillard S, Pourcher E, Cohen H. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia:a 1-year follow up study. Schizophr Res,2005,80(1):99-106
[10] Heyder K, Suchan B, Daum I. Cortico-subcortical contributions to executive control. Acta Psychological,2004,115:271-289
[11] Rusch N, Spoletini I, Wilke M, et al. Prefrontal-thalamiccerebellar gray matter networks and executive functioning in schizophrenia. Schizophr Res,2007,93(1-3):79-89

服务与反馈:
文章下载】【加入收藏
您是第访问者

《中国临床心理学杂志》编辑部
地址:湖南省长沙市中南大学湘雅二医院内, 410011
电 话:0731-85292472    电子邮件:cjcp_china@163.com
本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626